Reducing medications in older frail patients with muscle loss
Part of Brain & nervous system clinical trials.
This study looks at whether reducing certain medications in hospitalized older patients who are frail and have significant muscle loss is safe and beneficial. It aims to improve their overall health and function.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 70 years old or older
- You are frail, as determined by a standard questionnaire
- You have severe muscle loss, based on tests of grip strength, muscle mass, and physical function
- You take 5 or more different medications before coming to the hospital
- You are able to follow instructions and do not have an implantable defibrillator
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at muscle loss (sarcopenia) that can happen quickly in older adults during a hospital stay. It aims to understand how common it is and what factors might contribute, which could help improve care for patients.
This study looks at how diet and gut health relate to muscle loss (sarcopenia) in adults 60 and older. It aims to understand links between inflammation, gut bacteria, and muscle strength so we can find better ways to prevent frailty.
This study looks at muscle changes in people with or at risk for sarcopenia (age-related muscle loss). It aims to find better ways to detect and manage sarcopenia using simple tests like muscle strength and body composition measurements.
This study tests if a combination of a medicine (nandrolone), physical therapy, and a special diet can help older adults with muscle loss (sarcopenia) improve their strength and muscle mass. It is for people age 60 to 99 who have been diagnosed with sarcopenia based on specific muscle strength and mass measurements.
This study tests a phase 1 cardiac rehabilitation program for people aged 60 or older who have both coronary heart disease and sarcopenia (muscle loss). The program aims to improve heart health and muscle strength, potentially helping you recover better after a heart event.
This trial tests an investigational drug called AMC6156 to see if it can help improve muscle mass and strength in older adults with sarcopenia (age-related muscle loss). Participants will also follow exercise and nutrition guidance.
Hear when a new Sarcopenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.